Kuo Chih-Yun, Hsiao Hung-Ta, Lo Ing-Hsien, Nikolai Tomas
Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine and General University Hospital in Prague, Charles University, Prague, Czechia.
Soteria Biotech Co, Ltd., New Taipei City, Taiwan.
Front Aging Neurosci. 2021 Jan 6;12:591737. doi: 10.3389/fnagi.2020.591737. eCollection 2020.
Obstructive sleep apnea (OSA) and Alzheimer's disease (AD) are common in the elderly population. Obstructive sleep apnea that may cause significant changes in the cerebrospinal fluid β-amyloid and T-tau and/or P-tau protein levels is often identified as a risk factor for development of AD. Although the underlying mechanisms of AD are still not fully understood, a hypothesis associating OSA with AD has been already proposed. In this systematic mini-review, we first discuss the recent findings supporting the association of OSA with an increased risk of AD and then provide evidence suggesting the positive effect of OSA treatment on a reduced risk of AD.
阻塞性睡眠呼吸暂停(OSA)和阿尔茨海默病(AD)在老年人群中很常见。可能导致脑脊液β-淀粉样蛋白和T- tau及/或P- tau蛋白水平发生显著变化的阻塞性睡眠呼吸暂停通常被认为是AD发病的一个风险因素。尽管AD的潜在机制仍未完全明确,但已有人提出了将OSA与AD联系起来的假说。在这篇系统性的小型综述中,我们首先讨论支持OSA与AD风险增加之间关联的最新研究发现,然后提供证据表明OSA治疗对降低AD风险具有积极作用。